|Articles|August 31, 2006

Hydralazine HCl Injection Recalled

Luitpold Pharmaceuticals, Inc. recalled several lots of Hydralazine HCl Injection (20 mg/mL, 1-mL single-dose vials), labeled with the "Novaplus" label, because the products contain particulates.

Luitpold Pharmaceuticals, Inc. recalled several lots of Hydralazine HCl Injection (20 mg/mL, 1-mL single-dose vials), labeled with the “Novaplus” label, because the products contain particulates. (Aug. 3 and Aug. 25). For more information, see:
www.fda.gov/medwatch/safety/2006/safety06.htm#Hydralazine

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!